These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 8092942)
1. [Expression of a series of leukocyte and non-leukocyte antigens in breast cancer tissues after local irradiation as a morphologic manifestation of the interaction of parenchymal cells and tumor stroma]. Dorosevich AE; Dubenskaia LI; Baryshnikov AIu; Abrosimov SIu Arkh Patol; 1994; 56(3):51-5. PubMed ID: 8092942 [TBL] [Abstract][Full Text] [Related]
2. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488 [TBL] [Abstract][Full Text] [Related]
3. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Tang Y; Kesavan P; Nakada MT; Yan L Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463 [TBL] [Abstract][Full Text] [Related]
4. KAI1 protein is down-regulated during the progression of human breast cancer. Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas. Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998 [TBL] [Abstract][Full Text] [Related]
6. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737 [TBL] [Abstract][Full Text] [Related]
7. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity. Popiela TJ; Rudnicka-Sosin L; Dutsch-Wicherek M; Klimek M; Basta P; Galazka K; Wicherek L Neuro Endocrinol Lett; 2006 Dec; 27(6):786-94. PubMed ID: 17187007 [TBL] [Abstract][Full Text] [Related]
8. CD95 ligand expression in dedifferentiated breast cancer. Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600 [TBL] [Abstract][Full Text] [Related]
9. Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients. Suefuji Y; Sasatomi T; Shichijo S; Nakagawa S; Deguchi H; Koga T; Kameyama T; Itoh K Br J Cancer; 2001 Apr; 84(7):915-9. PubMed ID: 11286471 [TBL] [Abstract][Full Text] [Related]
10. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Kuninaka S; Yano T; Yokoyama H; Fukuyama Y; Terazaki Y; Uehara T; Kanematsu T; Asoh H; Ichinose Y Cytokine; 2000 Jan; 12(1):8-11. PubMed ID: 10623436 [TBL] [Abstract][Full Text] [Related]
11. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer. Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283 [TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells. Fan P; Wang S; Liu X; Zhen L; Wu Z Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):327-30. PubMed ID: 12408756 [TBL] [Abstract][Full Text] [Related]
13. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140 [TBL] [Abstract][Full Text] [Related]
14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical characteristics of breast cancer after radiation treatment]. Lushnikov EF; Dorosevich AE Med Radiol (Mosk); 1983 Nov; 28(11):39-42. PubMed ID: 6645829 [TBL] [Abstract][Full Text] [Related]
16. P7 antigen expression in human breast cancer. Yang X; Groshen S; Formenti SC; Davidson NE; Press MF Clin Cancer Res; 2003 Jan; 9(1):201-6. PubMed ID: 12538470 [TBL] [Abstract][Full Text] [Related]
17. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110 [TBL] [Abstract][Full Text] [Related]
18. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056 [TBL] [Abstract][Full Text] [Related]
19. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697 [TBL] [Abstract][Full Text] [Related]
20. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas. Peterson JA; Blank EW; Ceriani RL Cancer Res; 1997 Mar; 57(6):1103-8. PubMed ID: 9067279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]